Rang	Name	Position
1	Mr. Craig Alexander Collard	CEO & Director
2	Ms. Ira Duarte	Executive VP & CFO
3	Mr. Mark E. Hensley	Executive VP & COO
4	Dr. William P. Forbes Pharm. D., Pharm.D.	Executive VP & Chief Development Officer
5	Melissa Jarel	Vice President of Legal
6	Mr. Ryan Craig	Vice President of Marketing
7	Mr. John Aiken	Executive Director of People Management & Training
8	Dr. John C. Arthur Ph.D.	Senior Vice President of Manufacturing Development
9	Mr. Robert Sullivan	Chief Commercial Officer
10	Mr. Brett Fleshman	Chief Business Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Rubric Capital Management LP	15,86%	9,42 Mio. USD
2	Clearline Capital LP	6,46%	3,84 Mio. USD
3	BlackRock Inc	5,33%	3,17 Mio. USD
4	Orbimed Advisors LLC	5,18%	3,08 Mio. USD
5	Velan Capital Investment Management LP	4,62%	2,75 Mio. USD
6	Vanguard Capital Management, LLC	4,12%	2,45 Mio. USD
7	Tejara Capital Ltd	3,44%	2,04 Mio. USD
8	TANG CAPITAL MANAGEMENT LLC	3,30%	1,96 Mio. USD
9	Palisade Capital Management LLc	3,24%	1,93 Mio. USD
10	Millennium Management LLC	2,15%	1,28 Mio. USD
11	Geode Capital Management, LLC	2,12%	1,26 Mio. USD
12	State Street Corp	2,03%	1,21 Mio. USD
13	JW Asset Management, LLC	1,98%	1,18 Mio. USD
14	New York State Common Retirement Fund	1,36%	0,81 Mio. USD
15	Pale Fire Capital SE	1,33%	0,79 Mio. USD
16	UBS Group AG	1,21%	0,72 Mio. USD
17	Congress Park Capital LLC	1,06%	0,63 Mio. USD
18	Richmond Brothers Inc	0,95%	0,56 Mio. USD
19	Renaissance Technologies Corp	0,91%	0,54 Mio. USD
20	Stonepine Capital Management Llc	0,74%	0,44 Mio. USD